India, Dec. 12 -- Lupin Manufacturing Solutions (LMS), a subsidiary ofglobal pharma major Lupin Limited, has announced a long-term strategic alliance with PolyPeptide Group AG, a specialised, global CDMO for peptide-based active pharmaceutical ingredients.

This collaboration aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for the rapidly expanding global peptides market. It also advances next-generation peptide therapeutics, including those for metabolics, supporting the long-term strategic growth of both organisations.

As part of the alliance, both companies will work towards expanding sourcing options and fortifying peptide supply chains to meet rising global demand for peptide APIs, i...